Skip to main content
. 2015 Jul 16;47(3):867–874. doi: 10.3892/ijo.2015.3085

Table I.

Candidate genes for CDDP in ESCC cells.

Cell Identities Gene Overexpressed/downregulated
4-2 98% RPTOR Overexpressed
82% JAK2 Downregulated
4-4 100% LRP1 Downregulated
100% OR512 Downregulated
4-7 97% CNTNAP2 precursor Downregulated
96% Protein CASP isoform Downregulated
93% IL-6 precursor Overexpressed
15-5 83% CAMKMT Downregulated
90% TRIM16L Overexpressed
78% PDE8B Downregulated
83% DENND3 Downregulated
92% ZFPM2 Downregulated
80% UMODL1 Downregulated
86% TRAV26-2 Overexpressed
84% CAMSAP2 Downregulated
80% TNFSF4 Overexpressed
15-8 100% ASTN2 Downregulated
100% KIAA0368 Overexpressed
94% RFX3 isoform Downregulated
100% AQP7 Overexpressed
100% GNA14 Downregulated
100% OR1N2 Overexpressed
100% INTS9 isoform Downregulated
100% RNF19a Downregulated
15-14 86% TSHSD7B Downregulated
94% PTBP1 Downregulated
90% MVB12B Downregulated
100% HEPHL1 precursor Downregulated
82% NELL1 isoform Downregulated
96% FHAD1 Downregulated
87% PCDH7 Downregulated
92% ROBO2 isoform/precursor Downregulated
92% RFPL3 Downregulated
15-15 92% MICAL4 Downregulated
15-19 89% LRRC38 Overexpressed
89% RAB3B Downregulated
100% SYT10 Downregulated

A total of 39 candidate genes from 8 resistant colonies were identified. CDDP, cisplatin; ESCC, esophageal squamous cell carcinoma.